Review

You have free access to this content

Redox signalling in cardiovascular disease

  1. Rebecca L. Charles,
  2. Philip Eaton Dr.*

Article first published online: 6 MAY 2008

DOI: 10.1002/prca.200780104

Issue

PROTEOMICS - Clinical Applications

PROTEOMICS - Clinical Applications

Special Issue: CARDIOVASCULAR PROTEOMICS

Volume 2, Issue 6, pages 823–836, No. 6 June 2008

Additional Information

How to Cite

Charles, R. L. and Eaton, P. (2008), Redox signalling in cardiovascular disease. Prot. Clin. Appl., 2: 823–836. doi: 10.1002/prca.200780104

Author Information

  1. King's College London, Department of Cardiology, Cardiovascular Division, The Rayne Institute, St Thomas' Hospital, London, UK

*Department of Cardiology, The Rayne Institute, St Thomas' Hospital, London, SE1 7EH, UK Fax: +44-20-7188-0970

Publication History

  1. Issue published online: 12 JUN 2008
  2. Article first published online: 6 MAY 2008
  3. Manuscript Received: 30 OCT 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (412K)

References

  • 1
    Griendling, K. K., FitzGerald, G. A., Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003, 108, 1912–1916.
  • 2
    Rhee, S. G., Redox signalling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 1999, 31, 53–59.
  • 3
    MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360, 23–33.
  • 4
    Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., Sleight, P., Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000, 342, 154–160.
  • 5
    Blumberg, J. B., Frei, B., Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on “The relationship between dose of vitamin E and suppression of oxidative stress in humans”. Free Radic. Biol. Med. 2007, 43, 1374–1376.
  • 6
    Smith, R. A., Porteous, C. M., Coulter, C. V., Murphy, M. P., Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem. 1999, 263, 709–716.
    Direct Link:
  • 7
    Ido, Y., Kilo, C., Williamson, J. R., Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 1997, 40 Suppl 2, S115–117.
  • 8
    Kannurpatti, S. S., Joshi, N. B., Energy metabolism and NAD-NADH redox state in brain slices in response to glutamate exposure and ischemia. Metab. Brain Dis. 1999, 14, 33–43.
  • 9
    Lipinski, B., Evidence in support of a concept of reductive stress. Br. J. Nutr. 2002, 87, 93–94; discussion 94.
  • 10
    Ghyczy, M., Boros, M., Electrophilic methyl groups present in the diet ameliorate pathological states induced by reductive and oxidative stress: a hypothesis. Br. J. Nutr. 2001, 85, 409–414.
  • 11
    Rajasekaran, N. S., Connell, P., Christians, E. S., Yan, L. J. et al., Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 2007, 130, 427–439.
  • 12
    Valadi, H., Valadi, A., Ansell, R., Gustafsson, L. et al., NADH-reductive stress in Saccharomyces cerevisiae induces the expression of the minor isoform of glyceraldehyde-3-phosphate dehydrogenase (TDH1). Curr. Genet. 2004, 45, 90–95.
  • 13
    Tanaka, M., Fujiwara, H., Yamasaki, K., Sasayama, S., Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischemic preconditioning in the rabbit. Cardiovasc. Res. 1994, 28, 980–986.
  • 14
    Sies, H., Dafre, A. L., Ji, Y., Akerboom, T. P., Protein S-thiolation and redox regulation of membrane-bound glutathione transferase. Chem. Biol. Interact. 1998, 111-112, 177–185.
  • 15
    Robin, E., Guzy, R. D., Loor, G., Iwase, H. et al., Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J. Biol. Chem. 2007, 282, 19133–19143.
  • 16
    Sauer, H., Wartenberg, M., Hescheler, J., Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 2001, 11, 173–186.
  • 17
    Akhter, S., Vignini, A., Wen, Z., English, A. et al., Evidence for S-nitrosothiol-dependent changes in fibrinogen that do not involve transnitrosation or thiolation. Proc. Natl. Acad. Sci. USA 2002, 99, 9172–9177.
  • 18
    Pagliaro, P., Mancardi, D., Rastaldo, R., Penna, C. et al., Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic. Biol. Med. 2003, 34, 33–43.
  • 19
    O'Donnell, V. B., Eiserich, J. P., Bloodsworth, A., Chumley, P. H. et al., Nitration of unsaturated fatty acids by nitric oxide-derived reactive species. Methods Enzymol. 1999, 301, 454–470.
  • 20
    Gallogly, M. M., Mieyal, J. J., Mechanisms of reversible protein glutathionylation in redox signalling and oxidative stress. Curr. Opin. Pharmacol. 2007, 7, 381–391.
  • 21
    Mallis, R. J., Buss, J. E., Thomas, J. A., Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem. J. 2001, 355, 145–153.
  • 22
    Barrett, W. C., DeGnore, J. P., Keng, Y. F., Zhang, Z. Y. et al., Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J. Biol. Chem. 1999, 274, 34543–34546.
  • 23
    Barrett, W. C., DeGnore, J. P., Konig, S., Fales, H. M. et al., Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 1999, 38, 6699–6705.
  • 24
    Humphries, K. M., Juliano, C., Taylor, S. S., Regulation of cAMP-dependent protein kinase activity by glutathionylation. J. Biol. Chem. 2002, 277, 43505–43511.
  • 25
    Sadidi, M., Geddes, T. J., Kuhn, D. M., S-thiolation of tyrosine hydroxylase by reactive nitrogen species in the presence of cysteine or glutathione. Antioxid. Redox Signal. 2005, 7, 863–869.
  • 26
    Chu, F., Ward, N. E., O'Brian, C. A., Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor cysteine. Carcinogenesis 2001, 22, 1221–1229.
  • 27
    Davis, D. A., Dorsey, K., Wingfield, P. T., Stahl, S. J. et al., Regulation of HIV-1 protease activity through cysteine modification. Biochemistry 1996, 35, 2482–2488.
  • 28
    Chu, F., O'Brian, C. A., PKC sulfhydryl targeting by disulfiram produces divergent isozymic regulatory responses that accord with the cancer preventive activity of the thiuram disulfide. Antioxid. Redox Signal. 2005, 7, 855–862.
  • 29
    Biteau, B., Labarre, J., Toledano, M. B., ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 2003, 425, 980–984.
  • 30
    Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V., Chumakov, P. M., Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004, 304, 596–600.
  • 31
    Salmeen, A., Andersen, J. N., Myers, M. P., Meng, T. C. et al., Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003, 423, 769–773.
  • 32
    Stamler, J. S., Lamas, S., Fang, F. C., Nitrosylation. the prototypic redox-based signalling mechanism. Cell 2001, 106, 675–683.
  • 33
    Mitchell, D. A., Morton, S. U., Fernhoff, N. B., Marletta, M. A., Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. USA 2007, 104, 11609–11614.
  • 34
    Hess, D. T., Matsumoto, A., Kim, S. O., Marshall, H. E., Stamler, J. S., Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 2005, 6, 150–166.
  • 35
    Greco, T. M., Hodara, R., Parastatidis, I., Heijnen, H. F. et al., Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 2006, 103, 7420–7425.
  • 36
    Sun, J., Xin, C., Eu, J. P., Stamler, J. S., Meissner, G., Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc. Natl. Acad. Sci. USA 2001, 98, 11158–11162.
  • 37
    Linke, K., Jakob, U., Not every disulfide lasts forever: disulfide bond formation as a redox switch. Antioxid. Redox Signal. 2003, 5, 425–434.
  • 38
    Brennan, J. P., Wait, R., Begum, S., Bell, J. R. et al., Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J. Biol. Chem. 2004, 279, 41352–41360.
  • 39
    Gitler, C., Zarmi, B., Kalef, E., General method to identify and enrich vicinal thiol proteins present in intact cells in the oxidized, disulfide state. Anal. Biochem. 1997, 252, 48–55.
  • 40
    Vogt, W., Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. Med. 1995, 18, 93–105.
  • 41
    Hoshi, T., Heinemann, S., Regulation of cell function by methionine oxidation and reduction. J. Physiol. 2001, 531, 1–11.
    Direct Link:
  • 42
    Santarelli, L. C., Wassef, R., Heinemann, S. H., Hoshi, T., Three methionine residues located within the regulator of conductance for K+ (RCK) domains confer oxidative sensitivity to large-conductance Ca2+-activated K+ channels. J. Physiol. 2006, 571, 329–348.
    Direct Link:
  • 43
    Levine, R. L., Mosoni, L., Berlett, B. S., Stadtman, E. R., Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 1996, 93, 15036–15040.
  • 44
    Shacter, E., Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 2000, 32, 307–326.
  • 45
    Berlett, B. S., Stadtman, E. R., Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272, 20313–20316.
  • 46
    Kamisaki, Y., Wada, K., Bian, K., Balabanli, B. et al., An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc. Natl. Acad. Sci. USA 1998, 95, 11584–11589.
  • 47
    Irie, Y., Saeki, M., Kamisaki, Y., Martin, E., Murad, F., Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc. Natl. Acad. Sci. USA 2003, 100, 5634–5639.
  • 48
    Schaur, R. J., Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Aspects Med. 2003, 24, 149–159.
  • 49
    Ceaser, E. K., Moellering, D. R., Shiva, S., Ramachandran, A. et al., Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem. Soc. Trans. 2004, 32, 151–155.
  • 50
    Levonen, A. L., Landar, A., Ramachandran, A., Ceaser, E. K. et al., Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 2004, 378, 373–382.
  • 51
    Sanchez-Gomez, F. J., Cernuda-Morollon, E., Stamatakis, K., Perez-Sala, D., Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol. Pharmacol. 2004, 66, 1349–1358.
  • 52
    Charles, R. L., Schroder, E., May, G., Free, P. et al., Protein sulfenation as a redox sensor: Proteomics studies using a novel biotinylated dimedone analogue. Mol. Cell. Proteomics 2007, 6, 1473–1484.
  • 53
    Ellis, H. R., Poole, L. B., Novel application of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole to identify cysteine sulfenic acid in the AhpC component of alkyl hydroperoxide reductase. Biochemistry 1997, 36, 15013–15018.
  • 54
    Poole, L. B., Karplus, P. A., Claiborne, A., Protein sulfenic acids in redox signaling. Annu. Rev. Pharmacol. Toxicol. 2004, 44, 325–347.
  • 55
    Poole, L. B., Zeng, B. B., Knaggs, S. A., Yakubu, M., King, S. B., Synthesis of chemical probes to map sulfenic acid modifications on proteins. Bioconjug. Chem. 2005, 16, 1624–1628.
  • 56
    Saurin, A. T., Neubert, H., Brennan, J. P., Eaton, P., Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc. Natl. Acad. Sci. USA 2004, 101, 17982–17987.
  • 57
    Jaffrey, S. R., Snyder, S. H., The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE. 2001, 2001, L1.
  • 58
    Sullivan, D. M., Wehr, N. B., Fergusson, M. M., Levine, R. L., Finkel, T., Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry 2000, 39, 11121–11128.
  • 59
    Brennan, J. P., Miller, J. I., Fuller, W., Wait, R. et al., The utility of N,N-biotinyl glutathione disulfide in the study of protein S-glutathiolation. Mol. Cell. Proteomics 2006, 5, 215–225.
  • 60
    Sommer, A., Traut, R. R., Diagonal polyacrylamide-dodecyl sulfate gel electrophoresis for the identification of ribosomal proteins crosslinked with methyl-4-mercaptobutyrimidate. Proc. Natl. Acad. Sci. USA 1974, 71, 3946–3950.
  • 61
    Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X. et al., Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090–1094.
    Direct Link:
  • 62
    Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994–999.
  • 63
    Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154–1169.
  • 64
    Wolters, D. A., Washburn, M. P., Yates, J. R., III, An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 2001, 73, 5683–5690.
  • 65
    Eaton, P., Protein thiol oxidation in health and disease: Techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic. Biol. Med. 2006, 40, 1889–1899.
  • 66
    Gorg, A., Obermaier, C., Boguth, G., Harder, A. et al., The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21, 1037–1053.
    Direct Link:
  • 67
    Gorg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665–3685.
    Direct Link:
  • 68
    Rabilloud, T., Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002, 2, 3–10.
    Direct Link:
  • 69
    Garlick, P. B., Davies, M. J., Hearse, D. J., Slater, T. F., Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ. Res. 1987, 61, 757–760.
  • 70
    Eaton, P., Byers, H. L., Leeds, N., Ward, M. A., Shattock, M. J., Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J. Biol. Chem. 2002, 277, 9806–9811.
  • 71
    Martinez-Ruiz, A., Lamas, S., Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch. Biochem. Biophys. 2004, 423, 192–199.
  • 72
    Sethuraman, M., McComb, M. E., Huang, H., Huang, S. et al., Isotope-coded affinity tag (ICAT) approach to redox proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in complex protein mixtures. J. Proteome Res. 2004, 3, 1228–1233.
  • 73
    Canton, M., Neverova, I., Menabo, R., Van Eyk, J., Di Lisa, F., Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H870–877.
  • 74
    Brennan, J. P., Bardswell, S. C., Burgoyne, J. R., Fuller, W. et al., Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J. Biol. Chem. 2006, 281, 21827–21836.
  • 75
    Burgoyne, J. R., Madhani, M., Cuello, F., Charles, R. L. et al., Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317, 1393–1397.
  • 76
    Gopalakrishna, R., Jaken, S., Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 2000, 28, 1349–1361.
  • 77
    Chu, F., Chen, L. H., O'Brian, C. A., Cellular protein kinase C isozyme regulation by exogenously delivered physiological disulfides–implications of oxidative protein kinase C regulation to cancer prevention. Carcinogenesis 2004, 25, 585–596.
  • 78
    Chu, F., Ward, N. E., O'Brian, C. A., PKC isozyme S-cysteinylation by cystine stimulates the pro-apoptotic isozyme PKC delta and inactivates the oncogenic isozyme PKC epsilon. Carcinogenesis 2003, 24, 317–325.
  • 79
    Ward, N. E., Chu, F., O'Brian, C. A., Regulation of protein kinase C isozyme activity by S-glutathiolation. Methods Enzymol. 2002, 353, 89–100.
  • 80
    Ward, N. E., Pierce, D. S., Chung, S. E., Gravitt, K. R., O'Brian, C. A., Irreversible inactivation of protein kinase C by glutathione. J. Biol. Chem. 1998, 273, 12558–12566.
  • 81
    Ward, N. E., Stewart, J. R., Ioannides, C. G., O'Brian, C. A., Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry 2000, 39, 10319–10329.
  • 82
    Adachi, T., Weisbrod, R. M., Pimentel, D. R., Ying, J. et al., S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 2004, 10, 1200–1207.
  • 83
    Santacruz-Toloza, L., Ottolia, M., Nicoll, D. A., Philipson, K. D., Functional analysis of a disulfide bond in the cardiac Na(+)-Ca(2+) exchanger. J. Biol. Chem. 2000, 275, 182–188.
  • 84
    Aghdasi, B., Reid, M. B., Hamilton, S. L., Nitric oxide protects the skeletal muscle Ca2+ release channel from oxidation induced activation. J. Biol. Chem. 1997, 272, 25462–25467.
  • 85
    Boraso, A., Williams, A. J., Modification of the gating of the cardiac sarcoplasmic reticulum Ca(2+)-release channel by H2O2 and dithiothreitol. Am. J. Physiol. 1994, 267, H1010–1016.
  • 86
    Xie, H., Zhu, P. H., Biphasic modulation of ryanodine receptors by sulfhydryl oxidation in rat ventricular myocytes. Biophys. J. 2006, 91, 2882–2891.
  • 87
    Eaton, P., Fuller, W., Shattock, M. J., S-thiolation of HSP27 regulates its multimeric aggregate size independently of phosphorylation. J. Biol. Chem. 2002, 277, 21189–21196.
  • 88
    Canton, M., Skyschally, A., Menabo, R., Boengler, K. et al., Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur. Heart J. 2006, 27, 875–881.
  • 89
    Han, B., Stevens, J. F., Maier, C. S., Design, synthesis, and application of a hydrazide-functionalized isotope-coded affinity tag for the quantification of oxylipid-protein conjugates. Anal. Chem. 2007, 79, 3342–3354.
  • 90
    Chen, J., Schenker, S., Frosto, T. A., Henderson, G. I., Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim. Biophys. Acta 1998, 1380, 336–344.
  • 91
    Eaton, P., Li, J. M., Hearse, D. J., Shattock, M. J., Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am. J. Physiol 1999, 276, H935–H943.
  • 92
    Chen, J., Henderson, G. I., Freeman, G. L., Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J. Mol. Cell. Cardiol. 2001, 33, 1919–1927.
  • 93
    Adachi, T., Pimentel, D. R., Heibeck, T., Hou, X. et al., S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 2004, 279, 29857–29862.
  • 94
    Galeva, N. A., Esch, S. W., Williams, T. D., Markille, L. M., Squier, T. C., Rapid method for quantifying the extent of methionine oxidation in intact calmodulin. J. Am. Soc. Mass Spectrom. 2005, 16, 1470–1480.
  • 95
    Musatov, A., Carroll, C. A., Liu, Y. C., Henderson, G. I. et al., Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 2002, 41, 8212–8220.
  • 96
    Gallego-Delgado, J., Lazaro, A., Osende, J. I., Barderas, M. G. et al., Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. J. Proteome Res. 2006, 5, 404–413.
  • 97
    Lindsey, M. L., Goshorn, D. K., Comte-Walters, S., Hendrick, J. W. et al., A multidimensional proteomic approach to identify hypertrophy-associated proteins. Proteomics 2006, 6, 2225–2235.
    Direct Link:
  • 98
    Kim, N., Lee, Y., Kim, H., Joo, H. et al., Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics 2006, 6, 1237–1249.
    Direct Link:
  • 99
    Bagnato, C., Thumar, J., Mayya, V., Hwang, S. I. et al., Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2007, 6, 1088–1102.
  • 100
    Banfi, C., Brioschi, M., Wait, R., Begum, S. et al., Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics 2006, 6, 1976–1988.
    Direct Link:
  • 101
    Weekes, J., Wheeler, C. H., Yan, J. X., Weil, J. et al., Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999, 20, 898–906.
    Direct Link:
  • 102
    Heinke, M. Y., Wheeler, C. H., Yan, J. X., Amin, V. et al., Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 1999, 20, 2086–2093.
    Direct Link:
  • 103
    Macri, J., Rapundalo, S. T., Application of proteomics to the study of cardiovascular biology. Trends Cardiovasc. Med. 2001, 11, 66–75.
  • 104
    Arnott, D., O'Connell, K. L., King, K. L., Stults, J. T., An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal. Biochem. 1998, 258, 1–18.
  • 105
    White, M. Y., Cordwell, S. J., McCarron, H. C., Prasan, A. M. et al., Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics 2005, 5, 1395–1410.
    Direct Link:
  • 106
    Heinke, M. Y., Wheeler, C. H., Chang, D., Einstein, R. et al., Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis 1998, 19, 2021–2030.
    Direct Link:
  • 107
    Jin, X., Xia, L., Wang, L. S., Shi, J. Z. et al., Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics 2006, 6, 1948–1956.
    Direct Link:
  • 108
    Tompkins, A. J., Burwell, L. S., Digerness, S. B., Zaragoza, C. et al., Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim. Biophys. Acta 2006, 1762, 223–231.
  • 109
    White, M. Y., Tchen, A. S., McCarron, H. C., Hambly, B. D. et al., Proteomics of ischemia and reperfusion injuries in rabbit myocardium with and without intervention by an oxygen-free radical scavenger. Proteomics 2006, 6, 6221–6233.
    Direct Link:
  • 110
    Mayr, M., Chung, Y. L., Mayr, U., Yin, X. et al., Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2135–2142.
Get PDF (412K)